Ipca Laboratories and Bhami’s Research Laboratory signs global licensing agreement for subcutaneous… EP News Bureau Jun 15, 2026 Agreement enables development and commercialisation of monoclonal antibody products for oncology and inflammatory diseases using…
OneSource Specialty Pharma enters into strategic licensing agreement with Bhami’s Research… EP News Bureau Jul 30, 2024 Partnership grants access to BRL’s HILOPRO technology, enhancing subcutaneous delivery of high-concentration biologic therapies…
